Insulet Corporation Profile Avatar - Palmy Investing

Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a tim…
Medical - Devices
US, Acton [HQ]

Cash Flow Statements

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
-49.00 -35.00 -25.00 -29.00 3.00 8.00 -12.00 15.00 41.00 35.00 98.00 84.00 -68.00 119.00 145.00
Operating Cash (Net)
-49.00 -35.00 -25.00 -29.00 3.00 8.00 -12.00 15.00 41.00 35.00 98.00 84.00 -68.00 119.00 145.00
Accounts Receivable
-6.00 -5.00 -3.00 -13.00 -4.00 -10.00 -9.00 12.00 -26.00 -22.00 -10.00 -15.00 -71.00 -51.00 -154.00
Accounts Payable
3.00 -1.00 4.00 2.00 10.00 - - 17.00 - - 27.00 21.00 36.00 7.00 -15.00 -2.00 -11.00
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
-3.00 -6.00 -48.00 -10.00 -7.00 -11.00 -15.00 -178.00 -210.00 -184.00 -73.00 14.00 -82.00 -191.00 -119.00
Capital Expenditure
-3.00 -6.00 -11.00 -10.00 -7.00 -11.00 -10.00 -22.00 -77.00 -162.00 -170.00 -166.00 -122.00 -157.00 -109.00
Purchases of Investments
- - - - - - - - - - - - - - -177.00 -297.00 -191.00 -150.00 -37.00 - - -7.00 -7.00
Sale/Maturity of Investment
- - - - - - - - - - - - - - 16.00 164.00 169.00 247.00 218.00 40.00 40.00 40.00
Property, Plant, Equipment (P&PE)
-3.00 -6.00 -11.00 -10.00 -7.00 -11.00 -10.00 -22.00 -77.00 -162.00 -170.00 -166.00 -122.00 -157.00 -109.00
Acquisitions (Net)
- - - - -37.00 - - - - - - -4.00 5.00 - - - - 170.00 166.00 - - -26.00 -3.00
Other Investing Activities
- - - - -37.00 - - - - - - - - -155.00 -137.00 -27.00 -170.00 -166.00 29.00 -40.00 -40.00
Financing Activities
Used Cash (Net)
-123.00 -27.00 -55.00 -3.00 -96.00 -4.00 - - -176.00 -304.00 -8.00 -73.00 -605.00 -40.00 -40.00 -13.00
Debt Repayment
-27.00 -32.00 -88.00 - - -2.00 -193.00 -5.00 -159.00 -98.00 -6.00 -663.00 -128.00 -45.00 -39.00 -27.00
Dividends Paid
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Common Stock
- - - - - - 6 105 20 10 7 19 33 59 507 51 33 40
Other Financing Activities
56.00 11.00 138.00 -1.00 -3.00 185.00 -2.00 330.00 387.00 -17.00 703.00 384.00 -28.00 16.00 26.00
Cash Balances
Begin of Period
56.00 127.00 113.00 93.00 57.00 149.00 151.00 122.00 137.00 272.00 113.00 213.00 922.00 806.00 623.00
End of Period
127.00 113.00 93.00 57.00 149.00 151.00 122.00 137.00 272.00 113.00 213.00 922.00 806.00 689.00 650.00
Change
71.00 -14.00 -19.00 -36.00 92.00 1.00 -28.00 14.00 135.00 -158.00 99.00 708.00 -115.00 -116.00 26.00
Non-Cash Balances
Depreciation and Amortization
5.00 5.00 8.00 11.00 11.00 12.00 15.00 13.00 13.00 15.00 27.00 55.00 57.00 63.00 72.00
Stock Based Compensation
4.00 5.00 7.00 9.00 12.00 22.00 19.00 23.00 31.00 - - 28.00 35.00 34.00 40.00 48.00
Other
6.00 5.00 -54.00 10.00 10.00 10.00 7.00 10.00 18.00 29.00 36.00 46.00 41.00 12.00 -155.00
Highlighted metrics
Free Cash Flow (FCF)
-52.00 -42.00 -36.00 -40.00 -3.00 -2.00 -23.00 -6.00 -36.00 -126.00 -72.00 -82.00 -190.00 -38.00 36.00
Cash Conversion Cycle (CCC)
114.00 108.00 57.00 74.00 22.00 46.00 49.00 80.00 60.00 136.00 106.00 147.00 332.00 288.00 337.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows
End of PODD's Analysis
CIK: 1145197 CUSIP: 45784P101 ISIN: US45784P1012 LEI: - UEI: -
Secondary Listings
PODD has no secondary listings inside our databases.